Gyre Therapeutics, Inc. GYRE Gyre — Segment Expenditure Addition To Long Lived Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gyre — segment expenditure addition to long lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s gyre — segment expenditure addition to long lived assets?
- Gyre Therapeutics, Inc. (GYRE) reported gyre — segment expenditure addition to long lived assets of $0 in Q1 2026.
- What does gyre — segment expenditure addition to long lived assets mean?
- This metric tracks the capital expenditures made by the segment to acquire or improve long-lived assets, such as property, plant, and equipment. It reflects the segment's investment in infrastructure and capacity to support long-term growth and operational capabilities. High levels of expenditure indicate active investment in the segment's future productive capacity.